Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-23-053398
Filing Date
2023-05-01
Accepted
2023-05-01 06:15:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 425 tm2314221d2_425.htm 425 48465
2 EXHIBIT 2.1 tm2314221d2_ex2-1.htm EX-2.1 63387
3 EXHIBIT 10.1 tm2314221d2_ex10-1.htm EX-10.1 31883
4 EXHIBIT 10.2 tm2314221d2_ex10-2.htm EX-10.2 32109
  Complete submission text file 0001104659-23-053398.txt   177454
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filed by) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Subject) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40021 | Film No.: 23869790
SIC: 2834 Pharmaceutical Preparations